Invivyd is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases.
By pairing state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering techniques, we are committed to developing a robust pipeline of product candidates which could be used in prevention or treatment of serious viral diseases, starting with COVID-19 and expanding into influenza and other high-need indications.
Invivyd’s leadership team is composed of seasoned executives with decades of combined experience developing and commercializing novel medicines for infectious diseases. Our leadership team includes individuals with extensive experience delivering vaccines that have helped protect people around the globe from serious viral threats, as well as leaders who have helped pioneer the development of monoclonal antibodies for use in the prevention and treatment of COVID-19.
Chief Scientific Officer
Chief Legal Officer & Corporate Secretary
Chief Financial Officer
Chief Human Resources Officer
Chief Commercial Officer
Chief Technology & Manufacturing Officer
Senior Vice President of Clinical Development and Medical Affairs
Director
Chairperson of the Board
Director
Director
Director
Director
To achieve our mission, we have entered into a number of strategic partnerships and continue to evaluate potentially synergistic partnering opportunities, such as commercial partnerships that would help ensure that our portfolio of product candidates are available to as many vulnerable people as possible. In addition, we are exploring opportunities to partner with universities, academic medical centers, or other biopharmaceutical companies that have interest in leveraging our unique platform-based approach for asset and technology research and development.
Please contact us to explore partnering opportunities